Correction to:​ impact of risk minimisation measures on the use of strontium ranelate in Europe:​ a multi-national cohort study in 5 EU countries by the EU-ADR Alliance

Berencsi, K.; Sami, A.; Ali, M. S.; Marinier, K.; Deltour, N.; Perez-Gutthann, S.; Pedersen, L.; Rijnbeek, P.; Van der Lei, J.; Lapi, F.; Simonetti, M.; Reyes, C.; Sturkenboom, M. C. J. M.; Prieto-Alhambra, D.

Affiliations

¹Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark

²Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK

³Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK

⁴Department of Pharmacoepidemiology, Servier, Suresnes, France

⁵RTI Health Solutions, Barcelona, Spain

⁶Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands

⁷Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy

⁸GREMPAL Research Group, Idiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III, Barcelona, Spain

⁹Julius Global Health, University Medical Center, Utrecht, The Netherlands

¹⁰Botnar Research Centre, Oxford, UK

Links

DOI: 10.1007/s00198-020-05314-2

PubMed: 32025756

WoS: 000515832100001

History

Online: 2020-02-05